Should Protocol Kidney Biopsies be a Part of Routine Post-Transplant Care? CON.
作者信息
Dang Sanjana, Francis Ross S
机构信息
Department of Kidney and Transplant Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia and Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
出版信息
Kidney360. 2025 Apr 1;6(4):504-506. doi: 10.34067/KID.0000000000000420.
Abstract
摘要
相似文献
1
Should Protocol Kidney Biopsies be a Part of Routine Post-Transplant Care? CON.移植肾活检方案应成为移植后常规护理的一部分吗？反对意见。
Kidney360. 2025 Apr 1;6(4):504-506. doi: 10.34067/KID.0000000000000420.
2
Protocol biopsies should be part of the routine management of kidney transplant recipients. Con.
Am J Kidney Dis. 2002 Oct;40(4):674-7. doi: 10.1053/ajkd.2002.36426.
3
Protocol Biopsy After Kidney Transplant: Clinical Application and Efficacy to Detect Allograft Rejection.肾移植术后方案活检：检测同种异体移植排斥反应的临床应用及疗效
Cureus. 2023 Feb 1;15(2):e34505. doi: 10.7759/cureus.34505. eCollection 2023 Feb.
4
Should Protocol Kidney Biopsies be a Part of Routine Post-Transplant Care? PRO.移植肾活检方案应成为移植后常规护理的一部分吗？正方观点。
Kidney360. 2025 Apr 1;6(4):501-503. doi: 10.34067/KID.0000000000000419. Epub 2024 Mar 21.
5
Risk factors for death in kidney transplant patients: analysis from a large protocol biopsy registry.肾移植患者死亡的风险因素：来自大型方案活检登记处的分析。
Nephrol Dial Transplant. 2019 Jul 1;34(7):1171-1181. doi: 10.1093/ndt/gfy131.
6
Defining the Etiology of Renal Allograft Dysfunction Using Banff 2019 Classification: Correlation with Post-Transplant Duration and Creatinine Levels-A Comprehensive Analysis of 200 Renal Biopsies at a Tertiary Care Medical Center Hospital.使用2019年班夫分类法定义肾移植功能障碍的病因：与移植后持续时间和肌酐水平的相关性——对一家三级医疗中心医院200例肾活检的综合分析
Int J Surg Pathol. 2024 Oct 3:10668969241283737. doi: 10.1177/10668969241283737.
7
Deep learning identified pathological abnormalities predictive of graft loss in kidney transplant biopsies.深度学习识别出预测肾移植活检中移植物丢失的病理性异常。
Kidney Int. 2022 Feb;101(2):288-298. doi: 10.1016/j.kint.2021.09.028. Epub 2021 Oct 30.
8
[Kidney transplant pathology].
Pathologe. 2011 Mar;32(2):124-34. doi: 10.1007/s00292-010-1406-y.
9
Pilot Randomized Trial Exploring the Impacts of Deceased Donor Kidney Procurement Biopsies on Organ Evaluation and Transplant Outcomes.探索已故供体肾获取活检对器官评估及移植结局影响的前瞻性随机试验
Cureus. 2025 Apr 4;17(4):e81728. doi: 10.7759/cureus.81728. eCollection 2025 Apr.
10
Protocol biopsies in pediatric renal transplant recipients on cyclosporine versus tacrolimus-based immunosuppression.环孢素与他克莫司免疫抑制方案治疗的小儿肾移植受者的方案活检。
Pediatr Nephrol. 2013 Mar;28(3):493-8. doi: 10.1007/s00467-012-2330-6. Epub 2012 Oct 31.
引用本文的文献
1
Should Protocol Kidney Biopsies Be a Part of Routine Post-Transplant Care? Commentary.移植肾活检方案是否应成为移植后常规护理的一部分？评论。
Kidney360. 2025 Apr 1;6(4):507-508. doi: 10.34067/KID.0000000000000548. Epub 2024 Aug 13.
本文引用的文献
1
Percutaneous Ultrasound-Guided Kidney Transplant Biopsy Outcomes: From the Nephrologist to the Radiologist Standpoint.经皮超声引导下肾移植活检结果：从肾脏病学家的角度到放射科医生的观点。
Kidney360. 2022 Aug 23;3(10):1746-1753. doi: 10.34067/KID.0000332022. eCollection 2022 Oct 27.
2
Diagnostic Potential of Minimally Invasive Biomarkers: A Biopsy-centered Viewpoint From the Banff Minimally Invasive Diagnostics Working Group.微创生物标志物的诊断潜力：来自 Banff 微创诊断工作组的活检为中心的观点。
Transplantation. 2023 Jan 1;107(1):45-52. doi: 10.1097/TP.0000000000004339. Epub 2022 Dec 8.
3
Long-term immunological outcomes of early subclinical inflammation on surveillance kidney allograft biopsies.早期亚临床炎症对监测肾移植活检的长期免疫结果。
Kidney Int. 2022 Dec;102(6):1371-1381. doi: 10.1016/j.kint.2022.07.030. Epub 2022 Aug 29.
4
Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study.肾移植纵向监测评估供体来源游离DNA监测见解（ADMIRAL）研究的临床结果。
Kidney Int. 2022 Apr;101(4):793-803. doi: 10.1016/j.kint.2021.11.034. Epub 2021 Dec 22.
5
Kidney Graft Surveillance Biopsy Utilization and Trends: Results From a Survey of High-Volume Transplant Centers.肾移植受者监测活检的应用和趋势：一项对高容量移植中心的调查结果。
Transplant Proc. 2020 Dec;52(10):3085-3089. doi: 10.1016/j.transproceed.2020.04.1816. Epub 2020 Jun 21.
6
The clinical and pathological significance of borderline T cell-mediated rejection.边缘型 T 细胞介导排斥反应的临床和病理学意义。
Am J Transplant. 2019 May;19(5):1452-1463. doi: 10.1111/ajt.15197. Epub 2019 Jan 22.
7
Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.移植后1年的亚临床排斥反应表型与同种异体肾移植的结局
J Am Soc Nephrol. 2015 Jul;26(7):1721-31. doi: 10.1681/ASN.2014040399. Epub 2015 Jan 2.
8
Long-term impact of subclinical inflammation diagnosed by protocol biopsy one year after renal transplantation.肾移植后 1 年通过方案活检诊断的亚临床炎症的长期影响。
Am J Transplant. 2011 Oct;11(10):2153-61. doi: 10.1111/j.1600-6143.2011.03695.x. Epub 2011 Aug 22.
9
Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study.肾移植患者接受他克莫司和霉酚酸酯治疗时早期方案活检无获益：一项随机研究
Am J Transplant. 2007 Nov;7(11):2538-45. doi: 10.1111/j.1600-6143.2007.01979.x. Epub 2007 Oct 1.
10
Safety and adequacy of renal transplant protocol biopsies.肾移植方案活检的安全性与充分性。
Am J Transplant. 2005 Aug;5(8):1992-6. doi: 10.1111/j.1600-6143.2005.00988.x.
Zotero 插件